HR Execs on the Move

Cerevel

www.cerevel.com

 
Cerevel Therapeutics is a biopharmaceutical company focused on developing new therapies to treat disorders of the central nervous system (CNS). The company has a portfolio of experimental neuroscience therapies, which include three clinical-stage compounds and several pre-clinical compounds designed to target a broad range of CNS disorders, including Parkinson`s, Alzheimer`s, epilepsy, schizophrenia and addiction. Headquartered in the Greater Boston area, Cerevel was formed in 2018 through a partnership between Bain Capital and Pfizer.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.cerevel.com
  • 222 Jacobs Street Suite 200
    Cambridge, MA USA 02141
  • Phone: 844.304.2048

Executives

Name Title Contact Details
Mark Bodenrader
 Interim Chief Financial Officer Profile
Paul Burgess
 Chief Business Development and Strategic Profile
Susan Altschuller
 Chief Financial Officer Profile
Jack Homsher
 VP, People and Organizational Capability Profile
Richard Gleeson
 Head of Clinical and R&D Technology Profile

Similar Companies

Axcan Pharma Inc

Axcan Pharma Inc is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Osco Drug

Osco Drug is a Springfield, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fralex Therapeutics

Fralex Therapeutics is a Etobicoke, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Prisma Imaging

BrainsWay

BrainsWay is an Israeli company with international operations that is engaged in the development of a medical device that uses H-coil for deep transcranial magnetic stimulation as a noninvasive treatment for depression.